Stocks and Investing Stocks and Investing
Wed, March 29, 2023

Ed Arce Maintained (TERN) at Hold with Increased Target to $11 on, Mar 29th, 2023


Published on 2024-10-28 02:28:11 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Terns Pharmaceuticals, Inc." (TERN) at Hold with Increased Target from $7 to $11 on, Mar 29th, 2023.

Ed has made no other calls on TERN in the last 4 months.



There are 2 other peers that have a rating on TERN. Out of the 2 peers that are also analyzing TERN, 0 agree with Ed's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ed


  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $19 on, Tuesday, February 7th, 2023
  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $14 on, Tuesday, December 20th, 2022
Contributing Sources